Amgen ١٦ مايو ٢٠٢٦ Amgen Inc stock (US0311621009): lungs cancer setback meets steady biotech cash flow - AD HOC NEWS
Amgen ١٥ مايو ٢٠٢٦ Alumis pulls back from would-be rival to Amgen’s Tepezza after assessing prospects - Fierce Biotech
Amgen ١٤ مايو ٢٠٢٦ Amgen stock (US0311621009): Biotech leader navigates patent cliffs and pipeline momentum - AD HOC NEWS
Amgen ١٢ مايو ٢٠٢٦ This Week’s Biopharma News: Amgen Deepens US Manufacturing Push - The Medicine Maker
Amgen ١٠ مايو ٢٠٢٦ Quantum firm hailed by Amgen tech leader as an ‘extraordinary platform’ plans IPO - Fierce Biotech
Amgen ٦ مايو ٢٠٢٦ Biopharma Manufacturing Expands in the U.S.: Amgen, Lilly Double Down on Capacity and Next-Gen Production - BioPharm International
Amgen ٤ مايو ٢٠٢٦ Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge? - 24/7 Wall St.
Amgen ٤ مايو ٢٠٢٦ Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge? - Yahoo Finance
Amgen ٤ مايو ٢٠٢٦ Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion - Fierce Pharma
Amgen ٢ مايو ٢٠٢٦ Biopharma bites: Novo rebrands Rybelsus as the Ozempic pill, and Amgen trims its pipeline - FirstWord Pharma
Amgen ١ مايو ٢٠٢٦ Repatha sales help Amgen overcome Prolia biosimilar hits in 1st quarter - Fierce Pharma